Literature DB >> 2461362

Induction of the expression of retinol-binding protein and transthyretin in F9 embryonal carcinoma cells differentiated to embryoid bodies.

D R Soprano1, K J Soprano, M L Wyatt, D S Goodman.   

Abstract

Studies were conducted to determine if the expression of the gene for retinol-binding protein (RBP) and/or transthyretin (TTR) could be induced upon differentiation of F9 teratocarcinoma cells to either visceral endoderm or parietal endoderm. Both TTR mRNA and RBP mRNA were undetectable in the undifferentiated F9 stem cells and in F9 cells differentiated to parietal endoderm. However, TTR mRNA and RBP mRNA were both detected in F9 cell aggregates differentiated to embryoid bodies (which contain visceral endoderm-like cells) by treatment of the aggregates in suspension with retinoic acid. TTR mRNA was observed at 3 days, and RBP mRNA at 5 days, after treatment of the F9 cell aggregates with retinoic acid. Both TTR mRNA and RBP mRNA were found to be specifically localized by in situ hybridization in the outer layer of cells (the visceral endoderm-like cells) of the embryoid bodies. Finally, synthesis and secretion of both RBP and TTR by F9 cell embryoid bodies was demonstrated by specific immunoprecipitation of each newly synthesized protein from the culture medium. These data thus demonstrate the production and presence of RBP mRNA and TTR mRNA, and the synthesis and secretion of RBP and TTR, by F9 cell embryoid bodies (specifically by visceral endoderm-like cells). This finding suggests that these two proteins may be synthesized by rodent embryos extremely early in embryonic development.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2461362

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  FoxA proteins regulate H19 endoderm enhancer E1 and exhibit developmental changes in enhancer binding in vivo.

Authors:  Lingyun Long; Brett T Spear
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

2.  Multiple cytochrome P-450 genes are concomitantly regulated by vitamin A under steady-state conditions and by retinoic acid during hepatic first-pass metabolism.

Authors:  A Catharine Ross; Christopher J Cifelli; Reza Zolfaghari; Nan-Qian Li
Journal:  Physiol Genomics       Date:  2010-11-02       Impact factor: 3.107

3.  Adenovirus-mediated increase of HNF-3 levels stimulates expression of transthyretin and sonic hedgehog, which is associated with F9 cell differentiation toward the visceral endoderm lineage.

Authors:  Y Tan; R H Costa; I Kovesdi; R R Reichel
Journal:  Gene Expr       Date:  2001

4.  Elevated levels of insulin-like growth factor (IGF)-I in serum rescue the severe growth retardation of IGF-I null mice.

Authors:  Yingjie Wu; Hui Sun; Shoshana Yakar; Derek LeRoith
Journal:  Endocrinology       Date:  2009-06-04       Impact factor: 4.736

5.  Transthyretin is an inhibitor of monocyte and endothelial cell interleukin-1 production.

Authors:  L Borish; M S King; J J Mascali; S Johnson; B Coll; L J Rosenwasser
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

6.  Retinoic acid-mediated activation of HNF-3 alpha during EC stem cell differentiation.

Authors:  A Jacob; S Budhiraja; X Qian; D Clevidence; R H Costa; R R Reichel
Journal:  Nucleic Acids Res       Date:  1994-06-11       Impact factor: 16.971

7.  Elevated serum levels of IGF-1 are sufficient to establish normal body size and skeletal properties even in the absence of tissue IGF-1.

Authors:  Sebastien Elis; Hayden-William Courtland; Yingjie Wu; Clifford J Rosen; Hui Sun; Karl J Jepsen; Robert J Majeska; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2010-06       Impact factor: 6.741

8.  Human pluripotent embryonal carcinoma NTERA2 cl.D1 cells maintain their typical morphology in an angiomyogenic medium.

Authors:  Pedro D Simões; Teresa Ramos
Journal:  J Negat Results Biomed       Date:  2007-04-18

9.  Extra-embryonic endoderm cells derived from ES cells induced by GATA factors acquire the character of XEN cells.

Authors:  Daisuke Shimosato; Makoto Shiki; Hitoshi Niwa
Journal:  BMC Dev Biol       Date:  2007-07-03       Impact factor: 1.978

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.